Background: Arum hygrophilum is a traditional medicinal plant indigenous to Jordan. The present study explores its phytochemistry, antioxidative, antidiabesity, and antiproliferative potentialities. Materials and Methods: Column chromatography and HPLC-MS analysis were used for its phytochemical evaluation. Using leaf crude water and ethanol extracts, the antioxidative capacities, their modulation of pancreatic β-cell proliferation, and insulin secretion as well as glucose diffusion and enzymatic bioassays were evaluated. Results: Three flavonoids (luteolin, isoorientin, and vitexin) and β-sitosterol have been isolated and their structures determined. HPLC-MS analysis of the ethanol extract further revealed the presence of caffeic, ferulic, gallic, and rosmarinic acids and quercetine-3-O-rhamnoside. The ethanol extract exhibited DPPH and ABTS radical scavenging and antioxidative capacities. A. hygrophilum (1), vitexin (2), and rosmarinic acid (3) inhibited pancreatic lipase (PL) dose dependently with PL-IC 50 (µg/ mL) values in an ascending order: (3); 51.28 ± 7.55 < (2); 260.9 ± 21.1 < (1); 1720 ± 10. Comparable to GLP-1-enhanced β-cell proliferation in 2-day treatment wells, a dose-dependent augmentation of BrdU incorporation was obtained with the A. hygrophilum aqueous extract (AE) (0.5 and 1 mg/ mL, with respective 1.33-and 1.41-folds, P < 0.001). A. hygrophilum AE was identified as an inhibitor of α-amylase/α-glucosidase with IC 50 value of 30.5 ± 2.1 mg/mL but lacked antiproliferative effects in colorectal cancer cell lines (HT29, HCT116, and SW620) and insulinotropic effects in β-cell line MIN6. Conclusion: A. hygrophilum extracts inhibited gastrointestinal enzymes involved in carbohydrate and lipid digestion and absorption.
INTRODUCTION
Plants have been long used for the ethnomedical integrative/ complementary treatment of cancer and obesity-diabetes in various systems of medicine. [1] [2] [3] Type 2 diabetes and obesity, referred to as diabesity, comprise global health threats with rising prevalence. [4] Diverse studies were conducted to explore medicinal plants as potential therapeutic agents for dual management of diabetes and hyperlipidemia via digestive enzymes' inhibition, namely pancreatic α-amylase, intestinal α-glucosidase, and pancreatic lipase. [5, 6] In the Jordanian traditional medicine, the edible Arum species, referred with the common Arabic name "Louf, " are recommended as a natural anticancer agent against colon cancer. [7] Previously, different flavonoids, such as quercetin, apigenin, vitexin, and isoorientin were isolated from A. palaestinum in our laboratories and their antimicrobial activities were established. [8] In a recent comparative study in in vitro and in vivo experiments, pancreatic lipase (PL) and dual α-amylase/α-glucosidase inhibitory potentials were demonstrated for the extracts of A. dioscorides and A. palaestinum as well as for some of their isolated compounds. [9] Earlier, Karahan et al. [10] reported free radical scavenging and ferric-reducing activities of ethanol, methanol, acetone, and water extracts of A. dioscoridis leaves. The study concluded that total phenolic and flavonoid contents were greatly influenced by the extraction medium. Also, a literature survey indicated that A. hygrophillum is the least evaluated Arum species, lacking on both phytochemical and biological evaluations. This study investigates the indigenous A. hygrophilum phytochemically and biologically. The A. hygrophilum crude aqueous extract (AE) modulation of the extrapancreatic digestive enzymes was examined in vitro. Additionally, acute in vivo effects were investigated. Antiproliferative potential of this species against colorectal cancer cell lines as well as possible pancreatic effects in β-cell line was evaluated. 
MATERIALS AND METHODS

Plant material
Extraction and chromatographic separation
The air-dried flowers and leaves were coarsly powdered and extracted by soaking in EtOH for 3 weeks at RT. After solvent evaporation until dryness, the syrupy residue was extracted successively with CHCl 3 , EtOAc, and BuOH. Based on similar TLC profile, fractions of EtOAc and BuOH were combined and chromatographed on Silica gel columns (Silicagel 60, Merck) successively. Chloroform/methanol gradients were used for the extraction of flavonoids and plant acids. The isolated compounds were purified by repeated crystallization in MeOH. For the biological experiments, 10%% (w/v) AEs were prepared as reported earlier.
[11]
HPLC analysis
Crude EtOH extract was evaluated by HPLC. The experiments were based on the previously developed method published by Cristea et al., [12] adjusted to the current samples' specificity for the measurement of the plant acids and flavonoids. [12] The HPLC measurements were performed using a complete HPLC SHIMADZU system, using a Nucleosil 100-3. 
Antioxidant efficacy and free radical scavenging properties assessment
The radical scavenging activities of the ethanol extract of A. hygrophilum were evaluated using 2,2-diphenyl-1-pycriylhydrazyl (DPPH) and 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radicalscavenging activity assays and expressed as Trolox Equivalent. Antioxidant Capacity (TEAC). The antioxidant property was determined using Oxygen Radical Antioxidant Capacity (ORAC). [13, 14] Insulin secretion static incubation experiments Glucose-stimulated insulin secretion (GSIS) from MIN6 cells was determined using a static incubation protocol as described earlier. [15] Cell viability and proliferation assays Cell viability was assessed by a MTT kit on 96-well plates using kit's manufacturer protocol. Proliferation of MIN6 cells was evaluated with a colorimetric ELISA-based BrdU incorporation kit. Assays were performed in accordance with manufacturer protocol instructions. [15] Spectrophotometric quantification of PL activity and assaying PL inhibition of test extracts and compounds
The aqueous extract was evaporated until dryness under vacuum at 40°C using a rotary evaporator and dissolved in Tris-HCl buffer. The reference drug orlistat, rosmarinic acid, vitexin, and the AE were prepared in six different concentration ranges and in vitro enzymatic PL activity was assayed as described earlier in triplicates. [16, 17] In vitro enzymatic starch digestion assay
In vitro enzymatic starch digestion was assayed with acarbose as the reference drug. [18] The extent of polysaccharide breakdown into glucose was evaluated for the AE in seven concentrations (1, 5, 10, 12.5, 25, 50, and 100 mg/mL). The effects of acarbose at 1000 μg/mL concentration were performed in triplicates.
Glucose movement in vitro assay
In vitro glucose movement was assayed as described earlier with guar gum (50 mg/mL) as a positive control. [15] A. hygrophilum AEs 10, 25, and 50 mg/mL in 0.22 M glucose in triplicates were dialyzed against 0.15 M NaCl overnight at 37°C with gentle shaking. A parallel plant-free (negative) control was included. [19] In vivo confirmatory studies: Oral starch tolerance test (OSTT) and oral glucose tolerance test (OGTT)
OSTT and OGTT were conducted as described earlier in the Experimental Animal Laboratory of the School of Medicine, The University of Jordan using rats (Rattus rattus) of both sexes weighing 220-260 g, applying The University of Jordan ethical guidelines for animal protection. [20] Experimental approval was obtained from the Scientific Research Council at the Deanship of Academic Research. Aqueous extracts were administered under mild anesthesia in doses 125, 250, and 500 mg/kg body weight (n = 6 for each group).
In vitro antiproliferative assay
The cytotoxicity measurements with colorectal cell lines HT29, HCT116, and SW620 were determined using sulforhodamine B (SRB) colorimetric assay for cytotoxicity screening and mechanism of reduction of cell viability as described previously. [21] Doxorubicin IC 50 values were calculated within treatment concentration range 0.1-50 μg/mL.
Statistical analysis
The values are presented as mean ± standard error of mean (SEM) of three to six independent experiments. Statistical differences between control and different treatment groups and AUCs (incremental area under 24-h glucose curve) were determined using Graph Pad Prism one-way analysis of variance (ANOVA) followed by Dunnett's posttest whenever appropriate (version 3.02 for windows; Graph Pad Software, San Diego, CA, USA). AUCs, also, were calculated by Graph Pad Prism. Values were considered significantly different if P was less than 0.05 and highly significantly different if P was less than 0.01 and less than 0.001.
RESULTS AND DISCUSSION
Arum is a genus of about 26 species of flowering plants in the family Araceae, native to different parts of the globe with the highest species diversity in the Mediterranean region. In Jordan, it is represented by three species: A. palaestinum, A. dioscoridis, and A. hygrophilum. [22] In our previous investigations with the former two species, several flavonoids were isolated, and subsequently flavonoids, coumarins, and plant acids were identified using LC-MS. [8, 9] The isolated isoorientin showed myolytic activity on smooth muscle containing preparations from the rat and guinea pig. [23] Also, the antiproliferative activities of both species were evaluated using different cancer cell lines. [9, 24] In the present study, using conventional column chromatography, from the butanol and ethanol extracts of A. hygrophilum, three flavonoids (luteolin, isoorientin, and vitexin) and rosmarinic acid were isolated. Chloroform extract yielded β-sitosterol. The structures of the isolated compounds were determined using their physical properties and the different spectroscopic spectra (UV, IR, 1 H-NMR, 13 C-NMR).
The obtained results were in agreement with the values reported for them. [25] [26] [27] [28] For all isolated compounds, melting points and mixed melting points with the reference substances were determined and confirmed. HPLC-MS analysis of the ethanol extract revealed in addition to the isolated flavonoids the presence of quercetin-3-O-rhamnoside (3.33 mg/mL) and several plant acids, caffeic(3.33 mg/mL), ferulic (0.58 mg/mL), and gallic acid (3.58 mg/mL) [ Figure 1 ]. The in vitro antioxidant efficacy and Glucose-dependent modulation of glucose stimulated insulin secretion (GSIS) in pancreatic β-cell by A. hygrophilum AEs L-Alanine (10 mM) was used as a positive control, which enhanced substantially (P < 0.05) GSIS in MIN6 by 178.5 ± 17.9% (n = 4) following 1-h incubations, compared to untreated (glucose only) controls [ Figure 2 ]. [29] With obvious unlikeness to L-alanine, A. hygrophilum AE doses lacked any marked augmentation of MIN6 GSIS in acute treatment wells compared with controls [ Figure 2] . Surprisingly, A. hygrophilum AE (10 mg/mL) seemed to antagonize pancreatic GSIS significantly (P < 0.05) [ Figure 2 ]. Cell viability was unaffected, negating against plant inflected cytotoxicity. Changes in β-cell cytosolic Ca 2+ concentrations, whether by an influx of extracellular Ca 2+ or by release of Ca 2+ from intracellular stores, are thought to be a primary trigger for the initiation of insulin exocytosis machinery. Figure 2 illustrates that the marked insulinotropic trend of l-alanine was highly significantly (54.9 ± 8.6%, P < 0.001) abolished in Ca 2+ depleted KRH, as compared to corresponding Ca 2+ free glucose-only (negative control) wells. Apparently, Ca 2+ depleted A. hygrophilum treatments (0.01 mg/mL) had substantial reduction (P < 0.05) in pancreatic secretory function, compared with respective Ca 2+ buffered conditions [ Figure 2 ].
Pancreatic β-cell viability/expansion modulation by A. hygrophilum AEs
Compared to control untreated cells, the MTT method revealed that A. hygrophilum AEs (0.01-10 mg/mL) treatment in 48h post seeding preserved β-cell integrity. A. hygrophilum induced highly significantly pancreatic monolayers expansion by 1.23-1.76 folds (P<0.05-0.001 vs. basal plant-free control, Table 1 ). The higher concentrations, at C3' and C4' in ring B as well as C-glycosidic flavones favor the PL inhibition. [31] [32] [33] Additionally, the efficacy of phenolic acids, namely caffeic-, rosmarinic-, and ferulic acids, as PL inhibitors are well described. [34, 35] In effect, the results of the present study indicate that the PL inhibitory efficacy of A. hygrophilum may be attributable to their multiple phenolic components acting additively or synergistically. [36] In vitro extrapancreatic inhibitory effects of A. hygrophilum AE on α-amylase/α-glucosidase
In acarbose (0.1 mg/mL) incubations as the reference drug, glucose liberation from starch was inhibited by 97.6% highly substantially (P < 0.001, vs. drug-free control incubations, n = 3). With an IC 50 value of 30.5 ± 2.1 mg/mL, the significant dose-related (P < 0.001) percentage decreases in enzymatic starch hydrolysis by A. hygrophilum dosage gradient (1-10 mg/mL) are summarized in Table 2 . The overall dual α-amylase and α-glucosidase inhibitory propensities of A. hygrophilum could be the result of the combination of its several constituents performing in concert. Additionally, similar digestive enzymes modulatory outcomes were obtainable for both A. dioscoridis and A. palaestinum. [9, 18, 20] Extrapancreatic modulation of glucose movement in vitro by A. hygrophilum AEs Using the diffusion model as described; mean AUCs (area under 24-h glucose curve) for the viscous water-soluble gel-forming guar gum (50 mg/mL) were decreased highly significantly by 30.8 ± 2.5% (P < 0.001, n = 3) [ Figure 4 ] compared to overnight negative control. The efficacy of guar gum as a classical positive control has been elsewhere detailed. [37] Incomparable to guar gum, A. hygrophilum AEs (10, 25, and 50 mg/mL) lacked any marked glucose diffusional hindrances into external solution across dialysis membrane (with respective 8.1 ± 4.1%, 8.8 ± 5.1% AUC % reductions in A. hygrophilum 10, 25, and 50 mg/mL overnight incubations, P > 0.05) [ Figure 4 ].
Confirmatory in vivo studies: OSTT and OGTT
The administration of acarbose 3 mg/kg body weight reduced highly significantly the starch-induced postprandial hyperglycemia at 45, 90, and 135 min after corn starch load at 0 min, thus evoking highly substantial reduction (P < 0.001 vs. untreated animals, n = 6) of the overall glycemic excursion AUC compared to controls. Compared however, proved ineffective and noncytotoxic (the same table). A colorimetric immunoassay of BrdU incorporation into MIN6 β-cell genome was recruited to ascertain proliferative principles of chronic plants treatments. The gut hormone glucagon-like peptide-1 (GLP-1) agonists have been shown to stimulate the growth and differentiation of pancreatic cells, as well as to exert cytoprotective and antiapoptotic effects on β-cells. [30] GLP-1 (500 nM) highly significantly promoted a maximal extent of BrdU incorporation by 1.33-1.5-fold (P < 0.001, n = 4) in comparison to basal BrdU incorporation (spontaneous control). Similar to 48-h MTT findings, A. hygrophilum AE 0.5 and 1 mg/mL induced a highly substantial concentration related increase in pancreatic BrdU incorporation (with respective 1.33 and 1.41 folds, P < 0.001 vs. basal controls). With its safety profile, pancreatic proliferative capacities could be ascribed to A. hygrophilum AEs. This suggests the plant's potential utility in diabetes regenerative therapeutics. [15] The present study has revealed that water-soluble bioactive principles in A. hygrophilum AEs lacked any glucose-evoked insulin-releasing effect in pancreatic β-cells, unlike many other herbal remedies reputed for substantial insulin secretagogue activity. [15, 29] In vitro inhibitory effects of A. hygrophilum AEs, vitexin, and rosmarinic acid on PL activity PL inhibition is one of the most widely studied mechanisms to determine the potential efficacy of natural products and ethnomedicinal botanicals as obesity-modulating agents, since they are generally considered to be less toxic with less side effects than totally synthetic compounds. [16] In this current study, the pancreatic triacylglycerol antilipase activity profiles of the crude AE of A. hygrophilum, vitexin, and rosmarinic acid were determined [ Figure 3 ]. Orlistat's PL-IC 50 value of 114.0 ± 4.0 ng/mL, equivalent to 0.2 ± 0.0 μM, is comparable to reported PL-IC 50 values. [16] Comparable to orlistat performance, a marked concentrationdependent PL inhibition trend was obtained per tested extracts as well as their isolated components [ Figure 3 ]. PL-IC 50 values obtained for triple separate determinations are also illustrated [ Figure 3 ]. The importance of polyphenolic substances as potential inhibitors of PL were discussed recently by Buchholz and Melzig. [31] Several flavonoids, as the largest class of polyphenolic substances, have been evaluated and the studies indicated that the flavonoids having hydroxyl or methoxy groups Table 2 : Effect of ascending concentrations of A. hygrophilum (AE) (mg/mL) on percentage reduction of enzymatic starch digestion in vitro. Results expressed as percentage decrease in control values are mean ± SEM (n = 3 independent replicates). *P < 0.05 and ***P < 0.001 compared to control (drug-free or plant-free) incubations 
